Primary Cells Market Size To Reach $4.00 Billion By 2030

Primary Cells Market Growth & Trends

The global primary cells market size is anticipated to reach USD 4.00 billion by 2030, growing at a CAGR of 10.39% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to grow due to the increased demand for monoclonal antibodies, rising cancer research, growing preference for primary human cells over cell lines, and increasing government initiatives for cell-based research.

The surge in chronic diseases globally, such as cancer and autoimmune disorders, has led to a growing demand for targeted therapies like monoclonal antibodies. The adoption of these biopharmaceuticals is on the rise as they offer an effective treatment approach by selectively targeting diseased cells while minimizing the impact on healthy ones. The production of monoclonal antibodies often involves the use of primary cells, which are cells taken directly from living organisms or tissues. Primary cells retain the genetic and phenotypic characteristics of the original tissue or organism from which they were derived, making them more authentic models for studying biological processes and producing antibodies.

Moreover, human primary cells play a crucial role in research and development in the field of cell therapy. Cell therapy involves the transplantation of cells to replace or repair damaged tissues and organs, offering promising treatment options for various diseases and conditions. Human primary cells, derived directly from living tissue, provide a more physiologically relevant model than the immortalized cell lines, making them valuable tools in cell therapy research. Donor-to-donor variability, including HLA type and CMV status, in human primary cells is important for personalized medicine approaches in cell therapy as individual differences are likely to impact treatment outcomes. Furthermore, Contract Research Organizations (CROs) specializing in primary cell derivation provide researchers access to a wide range of services related to isolating and preparing primary cells from diverse tissue sources.

 Request a free sample copy or view report summary: Primary Cells Market Report

Primary Cells Market Report Highlights

• Human primary cells dominated the origin segment in 2023, owing to their importance in research as they closely resemble the physiological state of cells in vivo, thereby providing more biologically relevant data than immortalized cell lines.

• The hematopoietic cells type segment held the largest market share in 2023. On the other hand, skeletal and muscle cells segment is expected to grow at the highest CAGR of 12.51% from 2024 to 2030.

• In 2023, cancer research dominated the application segment and held the largest market share of 37.74%. Furthermore, the regenerative medicine segment is expected to grow at the highest CAGR over the forecast period.

• Based on end-use, the pharmaceuticals & biotechnology companies segment held the largest market share in terms of revenue in 2023.

• North America dominated the market for primary cells with a revenue share of 36.11% owing to the growing investments in the field of cancer research, cell therapies, and personalized and regenerative medicine.

Primary Cells Market Segmentation

Grand View Research has segmented the global primary cells market based on origin, type, application, end-use, and region:

Primary Cells Origin Outlook (Revenue, USD Million, 2018 - 2030)

• Human Primary Cells

• Animal Primary Cells

Primary Cells Type Outlook (Revenue, USD Million, 2018 - 2030)

• Hematopoietic Cells

• Skin Cells

• Hepatocytes

• Gastrointestinal Cells

• Lung Cells

• Renal Cells

• Heart Cells

• Skeletal and Muscle Cells

• Other Primary Cells

Primary Cells Application Outlook (Revenue, USD Million, 2018 - 2030)

• Drug Discovery and Development

• Regenerative Medicine

• Cancer Research

• Others

Primary Cells End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceuticals & Biotechnology Companies

• Academic & Research Institutes

• CROs

Primary Cells Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Primary Cells Market

• Thermo Fisher Scientific

• Merck KGaA

• Lonza

• Cell Biologics, Inc.

• PromoCell

• ZenBio

• STEMCELL Technologies

• AllCells

• American Type Culture Collection

• Axol Biosciences Ltd.